BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15926108)

  • 1. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
    Libé R; Mantovani G; Bondioni S; Lania AG; Pedroni C; Beck-Peccoz P; Spada A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):248-51. PubMed ID: 15926108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
    Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
    Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.
    Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA
    J Med Genet; 2004 Dec; 41(12):923-31. PubMed ID: 15591278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
    Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
    Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.
    Kirschner LS; Carney JA; Pack SD; Taymans SE; Giatzakis C; Cho YS; Cho-Chung YS; Stratakis CA
    Nat Genet; 2000 Sep; 26(1):89-92. PubMed ID: 10973256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors.
    Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos S; Robinson-White A; Lenherr S; Weinberg FD; Claflin E; Meoli E; Cho-Chung YS; Stratakis CA
    Cancer Res; 2004 Dec; 64(24):8811-5. PubMed ID: 15604237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency.
    Mavrakis M; Lippincott-Schwartz J; Stratakis CA; Bossis I
    Hum Mol Genet; 2006 Oct; 15(19):2962-71. PubMed ID: 16963469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein.
    Lania AG; Mantovani G; Ferrero S; Pellegrini C; Bondioni S; Peverelli E; Braidotti P; Locatelli M; Zavanone ML; Ferrante E; Bosari S; Beck-Peccoz P; Spada A
    Cancer Res; 2004 Dec; 64(24):9193-8. PubMed ID: 15604292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.
    Sandrini F; Matyakhina L; Sarlis NJ; Kirschner LS; Farmakidis C; Gimm O; Stratakis CA
    Genes Chromosomes Cancer; 2002 Oct; 35(2):182-92. PubMed ID: 12203783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal pathophysiology: lessons from the Carney complex.
    Groussin L; Cazabat L; René-Corail F; Jullian E; Bertherat J
    Horm Res; 2005; 64(3):132-9. PubMed ID: 16192737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that PKA activity is constitutively activated in human GH-secreting adenoma cells in a patient with Carney complex harbouring a PRKAR1A mutation.
    Takano K; Yasufuku-Takano J; Morita K; Mori S; Takei M; Osamura RY; Teramoto A; Fujita T
    Clin Endocrinol (Oxf); 2009 May; 70(5):769-75. PubMed ID: 19178533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRKAR1A gene mutation in patients with cardiac myxoma.
    Mabuchi T; Shimizu M; Ino H; Yamguchi M; Terai H; Fujino N; Nagata M; Sakata K; Inoue M; Yoneda T; Mabuchi H
    Int J Cardiol; 2005 Jul; 102(2):273-7. PubMed ID: 15982496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.
    Kool MM; Galac S; Spandauw CG; Kooistra HS; Mol JA
    J Vet Intern Med; 2013; 27(6):1486-92. PubMed ID: 24112376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and immunohistochemical investigation of protein kinase a regulatory subunit type 1A (PRKAR1A) in odontogenic myxomas.
    Perdigão PF; Stergiopoulos SG; De Marco L; Matyakhina L; Boikos SA; Gomez RS; Pimenta FJ; Stratakis CA
    Genes Chromosomes Cancer; 2005 Oct; 44(2):204-11. PubMed ID: 16001434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A alterations in adrenocortical tumors.
    Espiard S; Ragazzon B; Bertherat J
    Horm Metab Res; 2014 Nov; 46(12):869-75. PubMed ID: 25105543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
    Tadjine M; Lampron A; Ouadi L; Horvath A; Stratakis CA; Bourdeau I
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):367-73. PubMed ID: 18419788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
    Cazabat L; Ragazzon B; Groussin L; Bertherat J
    Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.
    Robinson-White A; Meoli E; Stergiopoulos S; Horvath A; Boikos S; Bossis I; Stratakis CA
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2380-8. PubMed ID: 16569736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.